An interventional study of Motivational Interviewing for Adult Kidney Transplant Recipients and Routine care in Motivational Interviewing, Adult and Kidney Transplantation, sponsored by Akdeniz University. Status unknown at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-31.
Sponsored by Akdeniz University · Not applicable, Interventional, and Supportive care
Purpose: This study aimed to determine the effect of motivational interviewing on self-management of treatment regimen, medication adherence, and patient outcomes in adult kidney transplant recipients between 3 months and 6 months after kidney transplant in the transplant outpatient clinic.
Design: The research is a single-centered, single-blind, parallel and 1:1 randomized active comparative experimental study.
Method: A total of 80 individuals, of the 40 in the control group and 40 in the intervention group, will be included in the study. Motivational interview sessions for the intervention group will be held 3 times between 15-30 minutes with an interval of 10 days. The control group will be given routine care (approximately 1 hour of face-to-face standard training) by the nurse educator. Within the research pattern, intervention and control groups will be applied pre-test at the first interview and post test after one month. In addition, follow-up test will be performed 3th month. The data will be obtained using the Self-Management Scale in Kidney Transplant Recipients, Visual Analog Scale (VAS) for self-care and VAS for medication adherence. In the study, Standard Protocol Items: Recommendations for Interventional Trials- SPIRIT(2013) and CONSORT 2010 (Consolidated Standards of Reporting Trials) were used.
Akdeniz University is the lead sponsor of 289 studies on the registry; 60 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Removing Criteria:
MIAKTR is an acronym that defines Motivational Interviewing for Adult Kidney Transplant Recipients
Behavioral: Motivational Interviewing for Adult Kidney Transplant Recipients
routine care
Other: Routine care
Motivational interviewing with individual sessions are planned to be conducted 3 times. Planned motivational interviews will be implemented the intervention group who are within 3th month, 4th month, 5th month and 6th month. Motivational interviewing will planned last 15-30 minutes with an interval of 10 days. The first interview will be performed face-to-face at the transplant outpatient clinic and the second and third ones will be phone interviews
The control group will be provided with routine care( face-to-face care standard training) by the nurse educator at the transplant outpatient clinic.
Self-management scale
The scale Turkish version includes 13 items, and it is likert type with 4 steps. Scale items are scored as 1 "never applied", 2 "applied slightly", 3 "applied very often" and 4 "fully applied". It is recommended to perform calculation based on the item mean scores instead of an overall mean. The lowest possible score obtained from each item and sub-scale is 1 and the highest possible score is 4. The scale has no cutoff points and reversed items.
Time frame: Change from Baseline Self Management at 3 months
VAS for medication adherence
Medication adherence will be evaluated with self reported scale the visual analog scale ranges from 0 to 100. Rating will be of 0 "taken no medications" to 100 "taken medications perfectly". A score different from 100 will be considered a non adherence
Time frame: Change from Baseline VAS for Medication Adherence at 3 months
VAS for self care
The rating will be done as 0-100. 0: "I cannot provide my own care".100:"I am able to provide my own care".
Time frame: Change from Baseline VAS for self care at 3 months
Glomerular Filtration Rate (GFR)
official measurements made by the hospital
Time frame: Change from Baseline GFR at 3 months
Serum Creatinine
official measurements made by the hospital
Time frame: Change from Baseline Serum Creatinine at 3 months
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Akdeniz University